RxDoctor Payments Data

Jack Burns, MD

Plastic and Reconstructive Surgery · Charleston, WVNPI 1922413889

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations.

$7,102in general payments, 2019–2025

Across 121 payments — averaging $58.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Integra Lifesciences Corporation$1K
  • Kerecis Limited$1K
  • Johnson & Johnson$799
  • Sientra, Inc.$787
  • Mentor Worldwide LLC$691
  • AbbVie$455
  • plus $2K from 14 others
$11,496in research payments, 2019–2025

Across 2 payments — averaging $5748.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Kerecis Limited$11K

What the payments were for

  • Food & beverage$6,70094%
  • Other$4026%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few plastic and reconstructive surgery providers in West Virginiato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$25,544
Medicare patients
77
Services billed
194

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin36$219
Oxycodone Hcl67$104

Paid to pharmacies, not to this prescriber.

Other plastic and reconstructive surgery in Charleston

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →